about
Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritisNon-pharmacological interventions for improving work participation in patients with inflammatory arthritisCombination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)Combination therapy for pain management in inflammatory arthritisCertolizumab pegol (CDP870) for rheumatoid arthritis in adultsA candidate gene study of CLEC16A does not provide evidence of association with risk for anti-CCP-positive rheumatoid arthritisCitrullination, a possible functional link between susceptibility genes and rheumatoid arthritisAutoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic valueBiological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review.The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysisDevelopment of macromolecular prodrug for rheumatoid arthritisMultiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapyFunctional variants in NFKBIE and RTKN2 involved in activation of the NF-κB pathway are associated with rheumatoid arthritis in JapaneseThe PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status.Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model.Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.Arthritis suppression by NADPH activation operates through an interferon-beta pathwaySystematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis.Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic patternAryl hydrocarbon receptor antagonism mitigates cytokine-mediated inflammatory signalling in primary human fibroblast-like synoviocytes.Mortality trends in rheumatoid arthritis: the role of rheumatoid factorRheumatic autoimmune diseases in women and midlife healthPrevalence of arthritis in India and Pakistan: a review.The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapyEffects of co-treatment with pioglitazone and methotrexate on experimentally induced rheumatoid arthritis in Wistar albino ratsEvaluation of Protective Efficacy of Avicennia marina (Forssk.) Vierh Leaves against Complete Freund᾽s Adjuvant-induced Arthritis in Wistar.Socioeconomic inequality in the prevalence of noncommunicable diseases in low- and middle-income countries: results from the World Health SurveyValidity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis.Personal mastery predicts pain, stress, fatigue, and blood pressure in adults with rheumatoid arthritis.Abatacept: the evidence for its place in the treatment of rheumatoid arthritis.Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis.Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern.Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations.Epidemiology and genetics of rheumatoid arthritis.IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trialGender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis.The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies.Segmentation of bones in magnetic resonance images of the wrist.
P2860
Q24188097-414EED5A-A6F0-41A0-A3BE-440F4C547E30Q24197632-70F2188A-872F-4F2E-9681-CFF83F2996E4Q24235846-59AFAC68-B3A8-4099-ACCD-4277290B68B6Q24236350-37F2ED35-1763-4EFF-B184-90094D7FAE55Q24242503-18373E96-1182-481C-87DD-A97DDB43A74EQ24634112-4C390275-163D-44F3-9401-4E4982EAC340Q24793137-8D000805-4615-458E-8E7F-ADA171AF3C4CQ24806041-52473CD2-E0C6-4267-8FD6-16B8A881C8A6Q24816745-7F21B0E3-02C2-472A-90D3-A5D7B83A8CCDQ27022403-4FDB1321-1124-4F52-B4C6-7DA2DB4718E8Q27693332-FAA46CE7-C7CC-4FC1-B3FD-2867DE07A3DAQ28475972-CDDB0E4F-A90F-4018-931B-22F34E67A962Q28943519-AE6FBF0E-C128-49F3-8FA5-FA001BE18A5BQ30160337-1E22657D-F874-4081-BF06-5A6B2FAA178AQ30495832-584DE204-0924-4415-906D-B5FBF9A5BF07Q30957102-3D920DC3-6581-49B9-8DC7-64DF41CA610EQ33284147-84FF1C4C-328D-4FA9-BF38-914260E153FFQ33400381-8439EB17-DF95-4969-B271-4D6A0E022D13Q33551313-B4362A9D-CEBB-45FF-A0AF-6EB2EF489F80Q33639777-23142896-A7C8-4B34-B358-A18648C72DE5Q33698322-E927F219-3776-4781-AC40-A8E3D8E879DBQ33709660-F9F8B616-8DB2-4A65-AE91-374611C717CFQ33727015-6909A41B-2837-405D-9721-4682D0E2E24FQ33823704-1881E5C0-BEC3-4C03-B9A8-2A713ACA4826Q33829772-B44CBFDA-6B8C-4D80-9644-4793438707B0Q33836681-CE64E7D8-4E66-4602-A0E9-609EB548E15EQ33872268-62758D7A-2040-40AE-A692-3C191CF36403Q34256337-3E031274-4717-44B9-9F78-367FC83F65F6Q34314892-5D6911F9-325D-4262-844E-9F0A45B6D438Q34346259-873BF813-0700-4972-8940-532B8B6A95E9Q34369990-F55B29CC-0EE3-41AD-B3E0-77066EC16738Q34449851-42BBFB99-4377-4476-971A-90AE2DFA2309Q34460622-CB049DCA-5A1D-40A6-8087-D8796D0CC701Q34495431-72BFCBE0-CCBE-401C-9DFE-8978632FAC55Q34575685-1679EA2D-61A6-4435-B408-BBC10201FA9CQ34731244-6CD174D1-E06C-4E31-B754-EC1542889D49Q34795777-57961CB3-A505-43DF-8518-97F87432988EQ34983577-636C96D5-557A-4F4F-B269-2E1262EB48C6Q35036116-C69E7E5B-BB96-4C7B-8B07-7728F398454CQ35232398-7FE8DE85-686C-4D4C-A225-0BFBDB78CF33
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The epidemiology of rheumatoid arthritis.
@ast
The epidemiology of rheumatoid arthritis.
@en
The epidemiology of rheumatoid arthritis.
@nl
type
label
The epidemiology of rheumatoid arthritis.
@ast
The epidemiology of rheumatoid arthritis.
@en
The epidemiology of rheumatoid arthritis.
@nl
prefLabel
The epidemiology of rheumatoid arthritis.
@ast
The epidemiology of rheumatoid arthritis.
@en
The epidemiology of rheumatoid arthritis.
@nl
P1476
The epidemiology of rheumatoid arthritis.
@en
P2093
Gabriel SE
P304
P356
10.1016/S0889-857X(05)70201-5
P577
2001-05-01T00:00:00Z